Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 530.00M
March 31, 2026 428.00M
December 31, 2025 545.00M
September 30, 2025 505.00M
June 30, 2025 539.00M
March 31, 2025 487.00M
December 31, 2024 468.00M
September 30, 2024 490.00M
June 30, 2024 416.00M
March 31, 2024 345.00M
December 31, 2023 352.00M
September 30, 2023 369.00M
June 30, 2023 367.00M
March 31, 2023 318.00M
December 31, 2022 345.00M
September 30, 2022 460.00M
June 30, 2022 507.00M
Date Value
March 31, 2022 342.00M
December 31, 2021 638.00M
September 30, 2021 453.00M
June 30, 2021 580.00M
March 31, 2021 515.00M
December 31, 2020 505.40M
September 30, 2020 670.60M
June 30, 2020 1.402B
March 31, 2020 1.217B
December 31, 2019 345.10M
September 30, 2019 320.30M
June 30, 2019 396.60M
March 31, 2019 300.60M
December 31, 2018 677.50M
September 30, 2018 934.90M
June 30, 2018 321.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 1.676B
Eli Lilly & Co. 8.95B
ANI Pharmaceuticals, Inc. 375.87M
EyePoint, Inc. 180.47M
Amylyx Pharmaceuticals, Inc. 250.76M